BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33298560)

  • 1. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
    Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
    Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
    ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model.
    Trindade-da-Silva CA; Clemente-Napimoga JT; Abdalla HB; Rosa SM; Ueira-Vieira C; Morisseau C; Verri WA; Montalli VAM; Hammock BD; Napimoga MH
    FASEB J; 2020 Jul; 34(7):9074-9086. PubMed ID: 32400048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration.
    Bartra C; Irisarri A; Villoslada A; Corpas R; Aguirre S; García-Lara E; Suñol C; Pallàs M; Griñán-Ferré C; Sanfeliu C
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
    Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
    Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
    CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
    Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
    Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
    Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
    Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
    Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
    Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
    Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
    Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
    Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
    Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
    Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
    Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
    Ma M; Ren Q; Yang J; Zhang K; Xiong Z; Ishima T; Pu Y; Hwang SH; Toyoshima M; Iwayama Y; Hisano Y; Yoshikawa T; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7083-7088. PubMed ID: 30890645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibitor (TPPU) alleviates ferroptosis by regulating CCL5 after intracerebral hemorrhage in mice.
    Wu Q; Jiang N; Wang Y; Song G; Li P; Fang Y; Xu L; Wang W; Xie M
    Biomed Pharmacother; 2024 Mar; 172():116301. PubMed ID: 38377737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.